Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3

A Bouma-de Krijger, FJ van Ittersum… - Clinical kidney …, 2019 - academic.oup.com
… that phosphate binder therapy in normophosphataemic patients with … effects of early treatment
of phosphate exposure in order to improve cardiovascular risks in all CKD Stage 3 patients

Cardiovascular effects of sevelamer in stage 3 CKD

CD Chue, JN Townend, WE Moody… - Journal of the …, 2013 - journals.lww.com
… of kidney function, use of phosphate binders reduces urinary … with Chronic Kidney Disease
Stage 3/4), in which 227 patients with … effects of phosphate binder therapy in early stage CKD. …

[HTML][HTML] The importance of phosphate control in chronic kidney disease

K Tsuchiya, T Akihisa - Nutrients, 2021 - mdpi.com
… in the early stage of CKD, suggesting possible phosphatephosphate binders to reduce
the level of FGF23 in patients … Taken together, the effect of phosphate binders on FGF23 …

[HTML][HTML] Modifying phosphate toxicity in chronic kidney disease

M Vervloet - Toxins, 2019 - mdpi.com
… , adapting phosphate binder types, using combination therapy, … In a small prospective trial
in patients with early stage CKD, … the detrimental cardiovascular consequences of phosphate

The pathophysiology of earlystage chronic kidney disease–mineral bone disorder (CKD‐MBD) and response to phosphate binders in the rat

SM Moe, JS Radcliffe, KE White… - Journal of Bone and …, 2011 - academic.oup.com
effect of phosphate binder therapy on PTH, FGF23, or 1,25(OH) 2 D 3 . The lack of effect of
phosphate binder could be due to the short intervention period and/or the early stage of CKD …

[HTML][HTML] The key role of phosphate on vascular calcification

M Cozzolino, P Ciceri, A Galassi, M Mangano… - Toxins, 2019 - mdpi.com
… -dialysis chronic kidney disease (CKD) patients, even in the early stage of the disease.
For … The idea to have iron-based phosphate binders beyond anemia treatment may help to …

[PDF][PDF] Vascular calcifications in chronic kidney disease–clinical management

IA Checheriţă, D Smarandache, C David… - Rom J Morphol …, 2012 - rjme.ro
… based phosphate binders should not be used in patients with … calcification progression,
still their effect is not potent enough … Osteogenesis associates with inflammation in early-stage

Effect of Lanthanum Carbonate on Serum Phosphate, Oxidative Stress, and Vascular Dysfunction in Chronic Kidney Disease

A Jovanovich, T Struemph, Z You, W Wang… - Kidney360, 2024 - journals.lww.com
… , a non-calcium phosphate binder, with placebo on vascular function and endothelial and …
Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease

[HTML][HTML] Protein-Bound uremic toxins lowering effect of sevelamer in Pre-Dialysis chronic kidney disease patients with hyperphosphatemia: a randomized controlled …

K Takkavatakarn, P Puapatanakul, J Phannajit… - Toxins, 2021 - mdpi.com
… Furthermore, despite the declined renal function, patients with early stage CKD were able
to … -based phosphate binders in reducing cardiovascular toxic substances in CKD patients. …

Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease

CD Chue, NC Edwards, LJ Davis… - Nephrology Dialysis …, 2011 - academic.oup.com
… known direct haemodynamic effects of these agents. Patients on phosphate binders and
vitamin … function in early stage chronic kidney disease. Further work is required to determine the …